A novel shark VNAR antibody-based immunotoxin targeting TROP-2 for cancer therapy.
Xi X, Wang Y, An G, Feng S, Zhu Q, Wu Z, Chen J, Zuo Z, Wang Q, Wang MW, Gu Y.
Xi X, et al. Among authors: chen j.
Acta Pharm Sin B. 2024 Nov;14(11):4806-4818. doi: 10.1016/j.apsb.2024.08.023. Epub 2024 Aug 27.
Acta Pharm Sin B. 2024.
PMID: 39664437
Free PMC article.